The journal of Experimental and Clinical Urology published two papers compiling the findings derived from studies exploring the complex drug Uronext® applied to protect the urinary tract. The complex has demonstrated positive anti-adhesive and antibacterial effects against uropathogens in patients with recurrent lower urinary tract infections (UTIs).